Business
Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility
NEWPORT BEACH, Calif., May 05, 2025--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has entered into an amended and restated credit facility, replacing its existing $125 million credit agreement with a new $250 million credit facility with funds managed by Pharmakon Advisors, LP.
About this update from Evolus, Inc. Common Stock
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/0e4eb3f8e2de59ca3f8df697eee44e54"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1SRpOYPciXfXYDQZ6fru7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0e4eb3f8e2de59ca3f8df697eee44e54","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/eJFdoMvXrCI_7lDvl4GMig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/0e4eb3f8e2de59ca3f8df697eee44e54","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Refinanced Existing Credit Facility Drawing $150 Million at Close with $100 Million of Strategic Incremental Capacity","length":117,"tagName":"p","attribs":{}},{"type":"text","content":"NEWPORT BEACH, Calif., May 05, 2025--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has entered into an amended and restated credit facility, replacing its existing $125 million credit agreement with a new $250 million credit facility with funds managed by Pharmakon Advisors, LP.","length":395,"tagName":"p"},{"type":"text","content":"Highlights of the new facility include:","length":39,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Lowered Interest Rate: Reduced borrowing cost by 350 basis points (bps) based on current interest rates. The facility will mature five years from the funding date. Interest will be paid quarterly using the 3-month SOFR plus 5.00% per annum.","length":240,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Improved Structure & Financial Flexibility: Converted from an amortizing structure to a bullet maturity payment, with significantly reduced pre-payment fees, avoided any pre-payment fees from the existing facility, and additional consideration of 1% of the drawn value for the new facility, making it a cost-effective agreement.","length":332,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Increased Capital Availability: Added $100 Million of discretionary incremental capacity with a senior secured term loan of up to $25...